Exploring the intricate relationship between sleep, cognitive function, and the risk of Alzheimer's Disease in older adults.
Neurodegeneration and the accumulation of metabolic waste, such as beta-amyloid and tau proteins, are hallmarks of Alzheimer's Disease. The glymphatic system, a perivascular system in the brain, removes said metabolic waste during sleep. Consequently, sleep disturbances affect approximately 50% of older adults and are usually associated with cognitive impairment, which affects 10% of those aged ≥ 65 years and 50% of adults ≥ 85 years.
This project focuses on the benefits of dietary supplements (nicotinamide riboside, a form of vitamin B3) in improving sleep quality, duration, cognitive function, and serum biomarkers of cognitive function in older adults.
The specific outcomes of this project will be identified by the faculty mentor at the beginning of your collaboration.
| Length of commitment | About a semester; 3-5 months |
| Start time | Fall, Spring, Summer |
| Engagement format | In-Person |
| Level of collaboration | Large group collaboration (4+ students) |
| Potential benefits | Academic credit annd/or work study |
| Who is eligible | Undergraduate students with laboratory experience in molecular biology or biochemistry. Any undergraduate student in Nursing, Public Health, and Pharmacological, Biomedical, and Computer Sciences are encouraged to apply. |
Carleara Weiss
Assistant Professor
Nursing
Phone: (716) 829-3261
Email: carleara@buffalo.edu
The specific preparation activities for this project will be customized through discussions between you and your project mentor. Please be sure to ask them for the instructions to complete the required preparation activities.
sleep, cognitive function, Alzheimer's disease, biomarkers
